Human growth hormone

Sort By

Bioniche Pharma recombinant Human Growth Hormone (rHGH) represents the pinnacle of biotechnology-derived peptide engineering. Produced via advanced recombinant DNA technology in specialized expression systems, our HGH formulations feature a precise 191-amino acid sequence identical to endogenous human somatotropin, ensuring optimal receptor binding affinity and minimal immunogenicity.

CLINICAL PHARMACOLOGY & DYNAMICS

Bioniche Pharma rHGH exerts profound systemic effects by binding to specific transmembrane growth hormone receptors (GHR) located throughout target tissues. This initiates intracellular signaling cascades—primarily mediated by hepatic and local insulin-like growth factor 1 (IGF-1) synthesis—that stimulate linear bone growth, accelerate amino acid uptake, drive cellular protein synthesis, and promote lipolysis while enhancing nitrogen retention.

INDICATIONS & CLINICAL UTILITY
  • Long-term replacement therapy for pediatric and adult patients experiencing confirmed endogenous growth hormone deficiency (GHD) using Bioniche Pharma rHGH.
  • Management of growth failure associated with chronic renal insufficiency, Turner syndrome, or small-for-gestational-age (SGA) births under clinical supervision.
  • Therapeutic metabolic optimization and tissue regeneration protocols in documented catabolic wasting states or severe burn recovery utilizing Bioniche Pharma formulations.
CONTRAINDICATIONS & GENERAL PRECAUTIONS
  • Active malignant neoplasia or evidence of tumor growth; growth hormone therapy must be discontinued immediately if malignancy is diagnosed.
  • Acute critical illness complications following open heart surgery, abdominal surgery, multiple accidental trauma, or acute respiratory failure.
  • Known hypersensitivity to somatotropin or any stabilizing excipients present in the Bioniche Pharma lyophilized powder or reconstitution diluent.
SAFETY MONITORING & CLINICAL SURVEILLANCE

Patient monitoring during Bioniche Pharma rHGH therapy should include regular evaluation of fasting blood glucose, HbA1c, thyroid function panels (free T4/TSH), serum IGF-1 levels, and screening for fluid retention, peripheral edema, or carpal tunnel symptoms.

STORAGE & HANDLING

Store lyophilized Bioniche Pharma rHGH vials refrigerated between 2°C and 8°C protected from light. Following reconstitution with bacteriostatic water, maintain under refrigeration and utilize within recommended clinical stability windows. Do not freeze. Keep strictly out of reach and sight of children.